SC Engineering Subsidiary Cellontech Sees First-Half Operating Profit Surge 165% Year-on-Year

Cellontech, a subsidiary of SC Engineering, has continued its robust growth in both scale and profitability, achieving record-high results for the first half of the year.

Cellontech, a company specializing in biocollagen medical devices, announced on August 18 that its cumulative sales for the first half of this year reached 10 billion KRW, a 33.5% increase compared to the same period last year, while operating profit rose by 164.9% to 2.6 billion KRW. This marks the highest first-half performance since Cellontech became a subsidiary of SC Engineering in 2021.

In particular, operating profit demonstrated a triple-digit growth rate, with the company achieving 80.4% of last year's annual operating profit of 3.2 billion KRW within just the first half of the year. During the same period, net profit also maintained a stable upward trend, increasing by 59.0% year-on-year to 1.6 billion KRW.

This strong growth was primarily driven by robust sales of the flagship product, Cartizol. To strengthen its market responsiveness, Cellontech introduced a joint marketing strategy in 2024 and rapidly expanded Cartizol's presence in the intra-articular injection market through collaborations with LG Chem, Kolon Pharmaceutical, and Dongkook Pharmaceutical, thereby fueling performance growth.

In the first half of the year, Cellontech also achieved notable results in securing mid- to long-term growth drivers through global market expansion. Together with its domestic joint marketing partner Kolon Pharmaceutical, Cellontech signed supply contracts for the facial fillers Therapil and Lucigen in Thailand and Vietnam, and obtained its first overseas sales approval for Cartizol in Vietnam. In China, after successfully enrolling the first patient for clinical trials of the cartilage regeneration medical device Cartifil, clinical procedures for National Medical Products Administration (NMPA) sales approval have begun in earnest.

A Cellontech representative stated, "Based on the business growth confirmed by our strong first-half results, we will focus on continuously increasing corporate value in the second half of the year through collaboration strategies with local distribution networks in China and Latin America."

Meanwhile, on a consolidated basis, SC Engineering recorded sales of 79.5 billion KRW in the first half of this year, a 7.1% increase compared to the same period last year. The expansion in scale and improved profitability of its subsidiary Cellontech contributed to the consolidated results.

This content was produced with the assistance of AI translation services.